Phoenix Holdings Ltd. Biogen Inc. Transaction History

Phoenix Holdings Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $169,168 - $203,634	760 New	760 $196,000
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $603,898 - $697,823	2,194 New	2,194 $624,000
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $258,101 - $325,194	-1,332 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $45,231 - $58,129	-202 Reduced 13.17%	1,332 $319,000
Q3 2021 Oct 27, 2021	BUY	$282.99 - $369.05 $434,106 - $566,122	1,534 New	1,534 $437,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $478,891 - $766,798	-1,849 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $126,091 - $147,722	519 Added 39.02%	1,849 $510,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $1.75 Million - $2.64 Million	-7,416 Reduced 84.79%	1,330 $323,000
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $475,262 - $548,749	1,795 Added 25.82%	8,746 $2.33 Million
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $1,293 - $1,712	-5 Reduced 0.07%	6,951 $1.72 Million
Q1 2020 May 20, 2020	BUY	$268.85 - $341.04 $1.87 Million - $2.37 Million	6,956 New	6,956 $2.13 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.